Uromune is a bacterial vaccine in individual presentation for treating recurring urinary tract infections. Its administration path is sublingual in daily doses.

It will be promoted exclusively by Q Pharma Laboratories, a company specialized in urology and gynecology products with a wide experience in these fields.